Swing Therapeutics

A young woman sitting near a window using a smartphone
Why leading with evidence is necessary for digital therapeutics
By Emily Olsen | 12:39 pm | June 27, 2022
Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.
A woman using smartphone
Swing Therapeutics raises $10.3M for fibromyalgia DTx clinical trial
By Emily Olsen | 11:33 am | June 17, 2022
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
Person sitting at a desk with a laptop touching their neck
Swing Therapeutics lands FDA breakthrough designation for fibromyalgia platform
By Mallory Hackett | 01:43 pm | August 17, 2021
With this designation, Swing is launching a real-world clinical trial to assess its fibromyalgia DTx.